
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) reported its financial and operating results for the fourth quarter and year ended December 31, 2021.
Highlights include record fiscal year 2021 revenue and Adjusted EBITDA¹ of $1.2 billion and $298 million, representing an increase of 93% and 107%, respectively; fourth-quarter 2021 Revenue and Adjusted EBITDA of $320 million and $80 million, representing an increase of 39% and 48% year-over-year, respectively